These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10551625)

  • 1. Clinical applications of proton magnetic resonance spectroscopy in the evaluation of common intracranial tumors.
    Castillo M; Kwock L
    Top Magn Reson Imaging; 1999 Apr; 10(2):104-13. PubMed ID: 10551625
    [No Abstract]   [Full Text] [Related]  

  • 2. Proton magnetic resonance spectroscopy (1H-MRS) for the evaluation of treatment of brain tumours.
    Houkin K; Kamada K; Sawamura Y; Iwasaki Y; Abe H; Kashiwaba T
    Neuroradiology; 1995 Feb; 37(2):99-103. PubMed ID: 7761009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo hydrogen-1 magnetic resonance spectroscopy study of human intracranial tumors.
    Luan W; Zhang J
    Chin Med J (Engl); 1998 Jan; 111(1):56-8. PubMed ID: 10322655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical value of proton magnetic resonance spectroscopy in adult brain tumours.
    Sibtain NA; Howe FA; Saunders DE
    Clin Radiol; 2007 Feb; 62(2):109-19. PubMed ID: 17207692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo 1H-spectroscopy of human intracranial tumors at 1.5 tesla. Preliminary experience at a clinical installation.
    Henriksen O; Wieslander S; Gjerris F; Jensen KM
    Acta Radiol; 1991 Mar; 32(2):95-9. PubMed ID: 2031809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-dimensional phosphorus-31 chemical shift imaging of human brain tumors.
    Rutter A; Hugenholtz H; Saunders JK; Smith IC
    Invest Radiol; 1995 Jun; 30(6):359-66. PubMed ID: 7490188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy.
    Preul MC; Caramanos Z; Collins DL; Villemure JG; Leblanc R; Olivier A; Pokrupa R; Arnold DL
    Nat Med; 1996 Mar; 2(3):323-5. PubMed ID: 8612232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton magnetic resonance spectroscopy and intracranial tumours: clinical perspectives.
    Falini A; Calabrese G; Origgi D; Lipari S; Triulzi F; Losa M; Scotti G
    J Neurol; 1996 Oct; 243(10):706-14. PubMed ID: 8923303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors.
    Demaerel P; Johannik K; Van Hecke P; Van Ongeval C; Verellen S; Marchal G; Wilms G; Plets C; Goffin J; Van Calenbergh F
    J Comput Assist Tomogr; 1991; 15(1):67-76. PubMed ID: 1846155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy.
    Kinoshita Y; Yokota A
    NMR Biomed; 1997 Jan; 10(1):2-12. PubMed ID: 9251109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential accumulation of 11C in human brain tumors after intravenous injection of 11C-1-pyruvate.
    Tsukiyama T; Hara T; Iio M; Kido G; Tsubokawa T
    Eur J Nucl Med; 1986; 12(5-6):244-8. PubMed ID: 3023098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of proton metabolite concentrations and relaxation parameters in normal human brain and intracranial tumours.
    Manton DJ; Lowry M; Blackband SJ; Horsman A
    NMR Biomed; 1995 May; 8(3):104-12. PubMed ID: 8579997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfusion MR imaging and MR spectroscopy of gemistocytic astrocytoma.
    Godefroy A; Derrey S; Laquerrière A; Perot G; Proust F; Gerardin E
    J Neuroradiol; 2012 Jul; 39(3):190-4. PubMed ID: 22115534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta-like activity in tumors of the central nervous system.
    Clark WC; Bressler J
    J Neurosurg; 1988 Jun; 68(6):920-4. PubMed ID: 3163723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human primary brain tumour metabolism in vivo: a phosphorus magnetic resonance spectroscopy study.
    Cadoux-Hudson TA; Blackledge MJ; Rajagopalan B; Taylor DJ; Radda GK
    Br J Cancer; 1989 Sep; 60(3):430-6. PubMed ID: 2551360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Most frequent molecular and immunohistochemical markers present in selected types of brain tumors.
    Richterová R; Jurečeková J; Evinová A; Kolarovszki B; Benčo M; De Riggo J; Sutovský J; Mahmood S; Račay P; Dobrota D
    Gen Physiol Biophys; 2014; 33(3):259-79. PubMed ID: 24968406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation.
    Lehnhardt FG; Bock C; Röhn G; Ernestus RI; Hoehn M
    NMR Biomed; 2005 Oct; 18(6):371-82. PubMed ID: 15959923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance spectroscopy study of low grade extra and intracerebral human neoplasms.
    Tugnoli V; Tosi MR; Barbarella G; Ricci R; Leonardi M; Calbucci F; Bertoluzza A
    Oncol Rep; 1998; 5(5):1199-203. PubMed ID: 9683835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of cysteinyl-leukotriene formation in tissue slices from human intracranial tumors: evidence for their biosynthesis under in vivo conditions.
    Simmet T; Luck W; Winking M; Delank WK; Peskar BA
    J Neurochem; 1990 Jun; 54(6):2091-9. PubMed ID: 2338559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens.
    Cheng LL; Chang IW; Louis DN; Gonzalez RG
    Cancer Res; 1998 May; 58(9):1825-32. PubMed ID: 9581820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.